185 related articles for article (PubMed ID: 37580822)
1. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis.
Wu X; Wu G; Ma P; Wang R; Li L; Sun Y; Xu J; Li Y; Zhang T; Li Q; Yang Y; Wang L; Xin X; Qiao Y; Fang B; Lu Z; Zhou X; Chen Y; Liu Q; Fu G; Wei H; Huang X; Su B; Wang H; Zou H
Infect Dis Poverty; 2023 Aug; 12(1):73. PubMed ID: 37580822
[TBL] [Abstract][Full Text] [Related]
2. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
Dorward J; Khubone T; Gate K; Ngobese H; Sookrajh Y; Mkhize S; Jeewa A; Bottomley C; Lewis L; Baisley K; Butler CC; Gxagxisa N; Garrett N
Lancet HIV; 2021 Mar; 8(3):e158-e165. PubMed ID: 33549166
[TBL] [Abstract][Full Text] [Related]
3. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis.
Wu X; Wu G; Ma Y; Huang X; Yang Y; Cai Y; Luo G; Ma P; Qiao Y; Chen Y; Lin YF; Gao Y; Zhan Y; Song W; Wang Y; Wang R; Yang X; Sun L; Wei H; Li Q; Xin X; Wang L; Wang X; Xie R; Yang L; Meng X; Zhao J; Li L; Zhang T; Xu J; Fu G; Zou H
Lancet Reg Health West Pac; 2022 Dec; 29():100569. PubMed ID: 35966023
[TBL] [Abstract][Full Text] [Related]
4. Early outcomes after implementation of treat all in Rwanda: an interrupted time series study.
Ross J; Sinayobye JD; Yotebieng M; Hoover DR; Shi Q; Ribakare M; Remera E; Bachhuber MA; Murenzi G; Sugira V; Nash D; Anastos K;
J Int AIDS Soc; 2019 Apr; 22(4):e25279. PubMed ID: 30993854
[TBL] [Abstract][Full Text] [Related]
5. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
[TBL] [Abstract][Full Text] [Related]
8. Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention.
Wu Z; Zhao Y; Ge X; Mao Y; Tang Z; Shi CX; Chen C; Li Y; Qiu X; Nong G; Huang S; Luo S; Wu S; He W; Zhang M; Shen Z; Jin X; Li J; Brookmeyer R; Detels R; Montaner J; Wang Y
PLoS Med; 2015 Sep; 12(9):e1001874. PubMed ID: 26348214
[TBL] [Abstract][Full Text] [Related]
9. Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators.
King JT; Perkal MF; Rosenthal RA; Gordon AJ; Crystal S; Rodriguez-Barradas MC; Butt AA; Gibert CL; Rimland D; Simberkoff MS; Justice AC
JAMA Surg; 2015 Apr; 150(4):343-51. PubMed ID: 25714794
[TBL] [Abstract][Full Text] [Related]
10. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
11. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini.
Kerschberger B; Jobanputra K; Schomaker M; Kabore SM; Teck R; Mabhena E; Lukhele N; Rusch B; Boulle A; Ciglenecki I
J Int AIDS Soc; 2019 Oct; 22(10):e25401. PubMed ID: 31647613
[TBL] [Abstract][Full Text] [Related]
14. Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.
Mendez-Lopez A; McKee M; Stuckler D; Granich R; Gupta S; Noori T; Semenza JC
HIV Med; 2019 Sep; 20(8):501-512. PubMed ID: 31140715
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing rapid antiretroviral therapy initiation in Jiulongpo, Chongqing, China: a retrospective cohort from 2018 to 2022.
Chen C; Chen H; Wu L; Gong Q; He J
AIDS Res Ther; 2024 Mar; 21(1):15. PubMed ID: 38494484
[TBL] [Abstract][Full Text] [Related]
16. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
[TBL] [Abstract][Full Text] [Related]
17. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
[TBL] [Abstract][Full Text] [Related]
18. HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort study.
Kerschberger B; Schomaker M; Jobanputra K; Kabore SM; Teck R; Mabhena E; Mthethwa-Hleza S; Rusch B; Ciglenecki I; Boulle A
J Int AIDS Soc; 2020 Mar; 23(3):e25458. PubMed ID: 32128964
[TBL] [Abstract][Full Text] [Related]
19. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
20. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
